123 related articles for article (PubMed ID: 1531219)
21. Interactions of hyperthermia with hypoxic cell sensitisers.
Bleehen NM; Walton MI; Workman P
Recent Results Cancer Res; 1988; 109():136-48. PubMed ID: 2972029
[No Abstract] [Full Text] [Related]
22. Panel report. Radiotherapy for lung cancer.
Rubin P
Cancer Chemother Rep 3; 1973 Mar; 4(2):311-5. PubMed ID: 4729336
[No Abstract] [Full Text] [Related]
23. Uptake and additivity of the radiosensitizing effects of Ro 03-8799 and SR-2508 in mammalian cells in vitro.
Watts ME; Dennis MF; Woodcock M
Br J Radiol; 1987 Dec; 60(720):1233-5. PubMed ID: 2961396
[No Abstract] [Full Text] [Related]
24. Effect of pH, oxygenation, and temperature on the cytotoxicity and radiosensitization by etanidazole.
Teicher BA; Herman TS; Holden SA
Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):723-31. PubMed ID: 1825994
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of fluorinated 2-nitroimidazole hypoxic cell radiosensitizers in murine peripheral nervous tissue.
Sasai K; Iwai H; Yoshizawa T; Nishimoto S; Shibamoto Y; Kitakabu Y; Oya N; Takahashi M; Abe M
Int J Radiat Biol; 1992 Aug; 62(2):221-7. PubMed ID: 1355516
[TBL] [Abstract][Full Text] [Related]
26. Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
Teicher BA; Herman TS; Holden SA; Jones SM
J Natl Cancer Inst; 1989 Jun; 81(12):929-34. PubMed ID: 2525198
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and subcellular localization of radiosensitizers.
Stratford MR
BJR Suppl; 1992; 24():100-4. PubMed ID: 1290683
[No Abstract] [Full Text] [Related]
28. Relationship between intracellular concentration and radiosensitizing effect of pimonidazole and etanidazole on two human melanoma cell lines.
el Gamoussi R; Stratford IJ; Guichard M
Int J Radiat Biol; 1993 Jan; 63(1):27-36. PubMed ID: 8093465
[TBL] [Abstract][Full Text] [Related]
29. A phase I-B trial of the radiosensitizer: etanidazole (SR-2508) with radiosurgery for the treatment of recurrent previously irradiated primary brain tumors or brain metastases (RTOG Study 95-02).
Drzymala RE; Wasserman TH; Won M; Shaw E; Cmelak AJ; Loeffler J; Souhami L;
Radiother Oncol; 2008 Apr; 87(1):89-92. PubMed ID: 18342381
[TBL] [Abstract][Full Text] [Related]
30. Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomas.
Eschwège F; Sancho-Garnier H; Chassagne D; Brisgand D; Guerra M; Malaise EP; Bey P; Busutti L; Cionini L; N'Guyen T; Romanini A; Chavaudra J; Hill C
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):275-81. PubMed ID: 9308928
[TBL] [Abstract][Full Text] [Related]
31. Additivity of radiosensitization by the combination of SR 2508 (etanidazole) and Ro 03-8799 (pimonidazole) in a murine tumor system.
Honess DJ; Wasserman TH; Workman P; Ward R; Bleehen NM
Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):671-5. PubMed ID: 2971028
[TBL] [Abstract][Full Text] [Related]
32. In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
Oya N; Shibamoto Y; Sasai K; Sugiyama T; Abe M
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1113-9. PubMed ID: 8262836
[TBL] [Abstract][Full Text] [Related]
33. [Paclitaxel and simultaneous radiotherapy in stage-III non-small-cell bronchial carcinoma].
Wolf M; Faoro C; Görg C; Merte H; Pfab R; Diergarten K; Havemann K
Strahlenther Onkol; 1996 May; 172 Suppl 1():5-8. PubMed ID: 8633270
[No Abstract] [Full Text] [Related]
34. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Taghian A; Lespinasse F; Guichard ME
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
[TBL] [Abstract][Full Text] [Related]
35. A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus.
Saunders MI; Anderson P; Dische S; Martin WM
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):347-50. PubMed ID: 7050036
[No Abstract] [Full Text] [Related]
36. Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03.
Coleman CN; Wasserman TH; Urtasun RC; Halsey J; Noll L; Hancock S; Phillips TL
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):389-93. PubMed ID: 2154420
[TBL] [Abstract][Full Text] [Related]
37. Progress report of a phase II and a phase III trial with etanidazole (SR-2508): a multicentre European study.
Chassagne D; Sancho-Garnier H; Charreau I; Eschwege F; Malaise EP
Radiother Oncol; 1991; 20 Suppl 1():121-7. PubMed ID: 1826960
[TBL] [Abstract][Full Text] [Related]
38. Estimation of plasma area under the curve for etanidazole (SR 2508) in toxicity prediction and dose adjustment.
Workman P; Ward R; Maughan TS; Newman HF; Bleehen NM
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):177-81. PubMed ID: 2526107
[TBL] [Abstract][Full Text] [Related]
39. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
[TBL] [Abstract][Full Text] [Related]
40. Targeting bioreductive drugs to tumours: is it necessary to manipulate blood flow?
Brown JM
Int J Radiat Biol; 1991; 60(1-2):231-6. PubMed ID: 1677976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
